This is a Validated Antibody Database (VAD) review about rat Frs2, based on 5 published articles (read how Labome selects the articles), using Frs2 antibody in all methods. It is aimed to help Labome visitors find the most suited Frs2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Santa Cruz Biotechnology
mouse monoclonal (A-5)
  • western blot; human
Santa Cruz Biotechnology Frs2 antibody (Santa Cruz Biotechnology, sc-17841) was used in western blot on human samples . Biochim Biophys Acta (2014) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 2c
Cell Signaling Technology Frs2 antibody (Cell Signaling Technology, 3864) was used in western blot on mouse samples (fig 2c). Redox Biol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s3f
Cell Signaling Technology Frs2 antibody (Cell Signaling, 3861) was used in western blot on human samples at 1:1000 (fig s3f). Nature (2018) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:30; loading ...; fig 1
Cell Signaling Technology Frs2 antibody (cell signalling, 3861) was used in immunocytochemistry on human samples at 1:30 (fig 1). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology Frs2 antibody (Cell Signaling, 3861) was used in western blot on human samples (fig 2a). Oncotarget (2016) ncbi
Articles Reviewed
  1. Li S, Zhu Z, Xue M, Pan X, Tong G, Yi X, et al. The protective effects of fibroblast growth factor 10 against hepatic ischemia-reperfusion injury in mice. Redox Biol. 2021;40:101859 pubmed publisher
  2. Frattini V, Pagnotta S, Tala -, Fan J, Russo M, Lee S, et al. A metabolic function of FGFR3-TACC3 gene fusions in cancer. Nature. 2018;553:222-227 pubmed publisher
  3. Feng S, Shao L, Castro P, Coleman I, Nelson P, Smith P, et al. Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors. Oncotarget. 2017;8:6179-6192 pubmed publisher
  4. Piasecka D, Kitowska K, Czaplinska D, Mieczkowski K, Mieszkowska M, Turczyk L, et al. Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells. Oncotarget. 2016;7:86011-86025 pubmed publisher
  5. Czaplinska D, Turczyk L, Grudowska A, Mieszkowska M, Lipinska A, Skladanowski A, et al. Phosphorylation of RSK2 at Tyr529 by FGFR2-p38 enhances human mammary epithelial cells migration. Biochim Biophys Acta. 2014;1843:2461-70 pubmed publisher